A detailed history of Guggenheim Capital LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Guggenheim Capital LLC holds 40,131 shares of CDNA stock, worth $948,295. This represents 0.01% of its overall portfolio holdings.

Number of Shares
40,131
Previous 41,817 4.03%
Holding current value
$948,295
Previous $649,000 92.91%
% of portfolio
0.01%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$14.41 - $33.99 $24,295 - $57,307
-1,686 Reduced 4.03%
40,131 $1.25 Million
Q2 2024

Aug 14, 2024

SELL
$7.56 - $16.15 $105,008 - $224,323
-13,890 Reduced 24.93%
41,817 $649,000
Q1 2024

May 14, 2024

SELL
$7.96 - $12.37 $17,591 - $27,337
-2,210 Reduced 3.82%
55,707 $589,000
Q4 2023

Feb 14, 2024

SELL
$4.9 - $12.86 $81,766 - $214,594
-16,687 Reduced 22.37%
57,917 $695,000
Q3 2023

Nov 14, 2023

SELL
$7.0 - $11.26 $25,396 - $40,851
-3,628 Reduced 4.64%
74,604 $522,000
Q2 2023

Aug 11, 2023

BUY
$7.61 - $9.46 $136,295 - $169,428
17,910 Added 29.69%
78,232 $664,000
Q1 2023

May 10, 2023

SELL
$8.83 - $17.61 $421,164 - $839,944
-47,697 Reduced 44.16%
60,322 $551,000
Q4 2022

Feb 14, 2023

BUY
$10.88 - $20.05 $59,437 - $109,533
5,463 Added 5.33%
108,019 $1.23 Million
Q3 2022

Nov 14, 2022

SELL
$16.06 - $26.39 $30,722 - $50,484
-1,913 Reduced 1.83%
102,556 $1.75 Million
Q2 2022

Aug 15, 2022

BUY
$20.49 - $39.72 $87,635 - $169,882
4,277 Added 4.27%
104,469 $2.25 Million
Q1 2022

May 16, 2022

BUY
$28.19 - $46.6 $142,895 - $236,215
5,069 Added 5.33%
100,192 $3.71 Million
Q4 2021

Feb 14, 2022

BUY
$41.2 - $73.6 $925,846 - $1.65 Million
22,472 Added 30.93%
95,123 $4.33 Million
Q3 2021

Nov 15, 2021

BUY
$59.15 - $91.99 $3.01 Million - $4.68 Million
50,919 Added 234.3%
72,651 $4.6 Million
Q2 2021

Aug 13, 2021

BUY
$63.02 - $95.11 $1.37 Million - $2.07 Million
21,732 New
21,732 $1.99 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.26B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.